首页>
外国专利>
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
展开▼
机译:雾化磷霉素/氨基糖苷类药物联合治疗细菌性呼吸道感染
展开▼
页面导航
摘要
著录项
相似文献
摘要
#$%^&*AU2012203623B220140410.pdf#####AEROSOLIZED FOSFOMYCIN/AMINOGLYCOSIDE COMBINATION FOR THE TREATMENT OF BACTERIAL RESPIRATORY INFECTIONS Abstract Aerosol formulations are described for the prevention and treatment of infection caused by susceptible bacteria in the respiratory tract of a patient. The formulation comprises from about I mg to about 300 mg of fosfomycin and about I mg to about 300 mg of an aminoglycoside selected from the group of gentamicin, kanamycin B, amikacin, arbekacin, dibekacin, streptomycin, neomycin, and netilmicin the formulation having a particle size distribution between 1 and 5 Pm and being adapted for administration by aerosolization or by dry powder inhaler. Also described are methods for the prevention and treatment of infections of the respiratory tract caused by bacteria comprising administering to a patient in need of such treatment such formulations.
展开▼